Minerva Neurosciences Inc (NYSE: NERV) — Healthcare · Share Price, Chart & Market Data
About: Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
Sector: Healthcare
Industry: Biotechnology
Latest price: $6.75 (+2.59%)
NERVMinerva Neurosciences Inc
Loading watchlist status…
Trade NERV now
Minerva Neurosciences Inc share price
NERV price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
27 Apr, 4:26 pm GMT+0
NERV price performance
-3.228%
5D
9.142%
1M
72.066%
YTD
276.816%
1Y
NERV price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
27 Apr, 4:26 pm GMT+0
NERV details
NERV Market Signals